Silverarc Capital Management, LLC Mersana Therapeutics, Inc. Call Options Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.23 - $2.25 $207,009 - $378,675
168,300 New
168,300 $318,000
Q4 2023

Feb 14, 2024
SELL
$1.11 - $2.34 $555,000 - $1.17 Million
-500,000 Reduced 62.38%
301,600 $699,000
Q3 2023

Nov 13, 2023
SELL
$1.06 - $3.91 $316,304 - $1.17 Million
-298,400 Reduced 27.13%
801,600 $1.02 Million
Q2 2023

Aug 14, 2023
BUY
$3.08 - $9.55 $3.39 Million - $10.5 Million
1,100,000 New
1,100,000 $3.62 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $194M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email